AI Outperforms Glaucoma, Retina Specialists for Diagnostic Accuracy
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Feb. 28, 2024 -- A large language model (LLM) chatbot outperforms glaucoma and retina specialists for diagnostic accuracy, according to a study published online Feb. 22 in JAMA Ophthalmology.
Andy S. Huang, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues conducted a comparative cross-sectional study recruiting 15 participants aged 31 to 67 years, including 12 attending physicians and three senior trainees, to compare the diagnostic accuracy and comprehensiveness of responses from an LLM chatbot with those of fellowship-trained glaucoma and retina specialists. Responses were assessed via a Likert scale for glaucoma and retina questions (10 of each type) in deidentified glaucoma and retina cases (10 of each type).
The researchers found that the combined question-case mean rank for accuracy was 506.2 and 403.4 for the LLM chatbot and glaucoma specialists, respectively; the corresponding mean ranks for completeness were 528.3 and 398.7. The mean rank for accuracy was 235.3 and 216.1 for the LLM chatbot and retina specialists, respectively; the corresponding mean ranks for completeness were 258.3 and 208.7. A significant difference was seen between all pairwise comparisons -- except for specialist versus trainee -- in rating chatbot completeness in the Dunn test. Compared with their specialist counterparts, both trainees and specialists rated the chatbot's accuracy and completeness more favorably, with specialists noting a significant difference in the accuracy and completeness of the chatbot.
"These findings support the possibility that artificial intelligence tools could play a pivotal role as both diagnostic and therapeutic adjuncts," the authors write.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults
FRIDAY, July 19, 2024 -- With respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females...
Concussions in Children Less Likely to Be Related to Sport
FRIDAY, July 19, 2024 -- For children aged 5 through 12 years with concussion, recreation-related concussion (RRC) and non-sport or recreation-related concussion (non-SRRC) occur...
Neighborhood Disadvantage Metrics Tied to Stress Genes in Prostate Cancer
FRIDAY, July 19, 2024 -- Expression of several stress-related genes in prostate tumors is elevated among men residing in disadvantaged neighborhoods, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.